clodronic acid has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diaconu, D; Loyd, CM; McCormick, TS; Michaels, CM; Ward, NL; Wolfram, JA | 1 |
| Haase, I; Hartmann, K; Krieg, T; Markur, D; Pasparakis, M; Peters, T; Rupec, RA; Scharffetter-Kochanek, K; Stratis, A; van Rooijen, N | 1 |
2 other study(ies) available for clodronic acid and Psoriasis
| Article | Year |
|---|---|
Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice.
Topics: Animals; Antigen-Presenting Cells; Antigens, CD; Bone Density Conservation Agents; Clodronic Acid; Cytokines; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Injections, Intradermal; Liposomes; Mice; Mice, Knockout; Neovascularization, Physiologic; Phenotype; Polymerase Chain Reaction; Psoriasis; Skin | 2011 |
Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation.
Topics: Animals; Clodronic Acid; Dendritic Cells; Disease Models, Animal; I-kappa B Kinase; Inflammation; Liposomes; Macrophages; Mice; Mice, Knockout; Phenotype; Psoriasis; Skin; T-Lymphocytes | 2006 |